Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...
ATLANTA -- Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to maintain their improvements in weight, body composition, and metabolic ...
Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...
Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...
Share on Pinterest The “golden dose” left in Mounjaro or Ozempic pens may do more harm than good, according to experts. Design by MNT; Photography by Bloomberg/Getty Images Over the last few years, ...
Low doses of a glucagon-like peptide-1 drug, a class better known for reshaping the weight loss market, are now being tested as tools to dial back biological wear and tear in older animals. Early work ...
Over the past few years, GLP-1 medications like Ozempic and Wegovy have reshaped the conversation around weight loss and metabolic health. For many, these medications have been life-changing. Yet, ...
GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results